Prices delayed by at least 15 minutes | Print
Solvonis Therapeutics PLC (SVNS)
ORD GBP0.001This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPPand can be used with Dividend reinvestment
Company profile
Solvonis Therapeutics PLC, formerly Graft Polymer (UK) PLC focuses on the development of polymer modification and drug delivery systems. It has licensed its Drug Delivery System platform IP to MGC Pharmaceuticals in relation to MGC Pharma's CimetrA product. The group's products address customer needs across a wide range of end-use markets, from automotive through to medical, and are not dependent on one market segment. The Company operates in two business segments being polymer development and production in Slovenia.
Address
Forecast key dates
| Name | Key Date |
|---|---|
| Solvonis Therapeutics PLC Second Quarter Earnings Results for 2026 | 2026-09-30T00:00:00 |
| Solvonis Therapeutics PLC Annual General Meeting for 2026 | 2026-06-26T12:00:00 |
| Solvonis Therapeutics PLC Fourth Quarter Earnings Results for 2025 | 2026-04-16T00:00:00 |
| Solvonis Therapeutics PLC Annual Report for 2025 | 2026-04-16T00:00:00 |
| Solvonis Therapeutics PLC Third Quarter Earnings Results for 2025 | 2026-02-24T00:00:00 |
Previous key dates
| Name | Key Date |
|---|---|
| Solvonis Therapeutics PLC Second Quarter Earnings Results for 2025 | 2025-09-30T00:00:00 |
| Solvonis Therapeutics PLC Annual General Meeting for 2025 | 2025-06-27T12:00:00 |
| Solvonis Therapeutics PLC Fourth Quarter Earnings Results for 2024 | 2025-04-16T00:00:00 |
| Solvonis Therapeutics PLC Annual Report for 2024 | 2025-04-16T00:00:00 |
| Solvonis Therapeutics PLC Third Quarter Earnings Results for 2024 | 2025-02-24T00:00:00 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2025 AJ Bell. All rights reserved.